International Journal of Obstetric Anesthesia
Volume 15, Issue 1 , Pages 59-62 , January 2006

Implications for anaesthesia in a patient established on clozapine treatment

,Accepted 24 April 2005.

References 

  1. Clozaril Patient Monitoring Service (CPMS). Clozapine Newsletter – Summer 1998.
  2. Goldberg HL, Nissim R. Psychotropic drugs in pregnancy and lactation. Int J Psychiatry Med. 1994;24:129–149
  3. Nguyen HN, Lalonde P. Clozapine and pregnancy. Encephale. 2003;29:119–124
  4. Gupta N, Grover S. Safety of clozapine in two successive pregnancies. Can J Psychiatry. 2004;49:12
  5. Dickson RA, Hogg L. Pregnancy of a patient treated with clozapine. Psychiatry Serv. 1998;49:1081–1083
  6. Waldman MD, Safferman AZ. Pregnancy and clozapine. Am J Psychiatry. 1993;150:168–169
  7. Williams JH, Hepner DL. Risperidone and exaggerated hypotension during a spinal anesthetic. Anesth Analg. 2004;98:240–241
  8. Novartis Pharmaceuticals. UK Limited, Data on File. April 1998.
  9. McGoldrick KE. Risperidone and exaggerated hypotension during a spinal anesthetic. Surv Anesthesiol. 2004;48:144
  10. Farde L, Wiesel FA, Nordström AL, Sedvall G. D1 and D2 dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology. 1989;99:S28–S31
  11. Andersen PH, Braestrup C. Evidence for different states of the dopamine D1 receptor; clozapine and fluperlapine may preferentially label an adenylate cyclase coupled state of the D1 receptor. J Neurochem. 1986;47:1822–1831
  12. Kane JM, Cooper TB, Sacher EJ, Halpern FS, Bailine S. Clozapine: plasma levels and clozapine response. Psychopharmacology. 1981;73:184–187
  13. Kalkman HO, Loetscher E. α2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. Eur J Pharmacol. 2003;462:33–40
  14. Lee T, Tank SW. Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain. Psychiatry Res. 1985;12:277–285
  15. Ernest CL, Goldberg JF. The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad spectrum psychotropics. J Clin Psychiatry. 2002;63(Suppl 4):42–55
  16. Bernstein JG. Induction of obesity by psychotropic drugs. Ann NY Acad Sci. 1987;499:203–215
  17. Nguyen HN, Lalonde P. Clozapine and pregnancy. Encephale. 2003;29:119–124
  18. Shiovitz TM, Welke TL, Tigel PD, et al. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal. Schizophr Bull. 1996;22:59
  19. Kamran A, Doraiswamy PM, Jane JL, Hammett EB, Dunn L. Severe hyperglycemia with high doses of clozapine. Am J Psychiatry. 1994;151:1395
  20. Markowitz JS, Grinberg R, Jackson C. Marked liver enzyme elevations with clozapine. J Clin Psychopharmacol. 1997;17:70–71
  21. Killian JG, Kerr K, Lawrence C, Celermajer DS. Myocarditis and cardiomyopathy associated with clozapine. Lancet. 1999;354:1841–1845
  22. La Grenade L, Graham D, Trontell A. Myocarditis and cardiomyopathy associated with clozapine use in the United States. N Engl J Med. 2001;345:224–225
  23. Young CR, Bowers MB, Mazure CM. Management of the adverse effects of clozapine. Schizophr Bull. 1998;24:381–390
  24. British National Formulary. September 2002, No. 44.
  25. Uvnas-Moberg K, Alster P, Svensson TH. Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats. Psychopharmacology (Berl). 1992;109:473–476
  26. Hägg S, Spigset O, Söderström TG. Association of venous thromboembolism and clozapine. Lancet. 2000;355:1155–1156

PII: S0959-289X(05)00103-2

doi: 10.1016/j.ijoa.2005.04.015

International Journal of Obstetric Anesthesia
Volume 15, Issue 1 , Pages 59-62 , January 2006

Article Tools